HIV/AIDS News

Even before I came to the United States to start my internal medicine residency, I had discovered that my calling was a career in infectious diseases.

HHS this week announced that it will allocate more than $1.4 billion in funding through the Ryan White HIV/AIDS Program to help people with HIV who have low incomes receive medication and care.

In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19.

People with virally suppressed HIV who are hospitalized with community acquired pneumonia do not have a higher mortality risk than people without HIV, according to a study.

A new study provides the first evidence that illicit fentanyl use may play a role in hepatitis C transmission among injection drug users, according to researchers.

CMS included a new infectious disease consult add-on code as part of its proposed new fee schedule could help improve compensation for ID clinicians, according to the Infectious Diseases Society of America.

Two experimental HIV vaccine regimens failed to reduce infections in a 3-year trial in eastern and southern Africa compared with participants who were taking a placebo, some of whom were on oral PrEP, according to a study.

ID is a dynamic field that is constantly changing. The types of infections we’re talking about today are different than what we may have been talking about 5 years ago. So, it’s intellectually stimulating and challenging.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.